![Victor Clavelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Victor M.
Clavelli served as President-Inflammation & Immunology at Pfizer Inc. from 2016 to 2019.
He then worked as Chief Commercial Officer at OptiNose, Inc. from 2020 to 2022.
Prior to his professional career, he earned an undergraduate degree from Fairfield University and an MBA from The Leonard N Stern School of Business.
Anciens postes connus de Victor Clavelli
| Sociétés | Poste | Fin |
|---|---|---|
| OPTINOSEPAR | Corporate Officer/Principal | 15/12/2022 |
| PFIZER INC. | Corporate Officer/Principal | 01/12/2019 |
Formation de Victor Clavelli
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
OptiNose, Inc.
 OptiNose, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for patients treated by ear, nose, throat and allergy diseases | Health Technology |
Fairfield University
 Fairfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
